In The Days

• Source: Washington Post
• News Date: 9/9/10
• Author: Rob Stein
• Submitted By: Seth Higgins

An appeals court Thursday lifted a temporary injunction barring the federal government from funding research involving human embryonic stem cell research.

To view dictionary popup window put your cursor on the blue words

Innocent Blood

“Yea, they sacrificed•Strongs 2076:zabach, zaw-bakh´; a primitive root; to slaughter an animal (usually in sacrifice):—kill, offer, (do) sacrifice, slay. their sons and their daughters unto devils, And shed innocent•Strongs 5355:naqiy, naw-kee´; or ayIqÃŽn naqiyi (Joel 4 : 19; Jonah 1 : 14), naw-kee´; from 5352; innocent:—blameless, clean, clear, exempted, free, guiltless, innocent, quit. blood, even the blood of their sons and of their daughters, whom they sacrificed unto the idols of Canaan: and the land was polluted•Strongs 2610:chaneph, khaw-nafe´; a primitive root; to soil, especially in a moral sense:—corrupt, defile, x greatly, pollute, profane. with blood. Thus were they defiled with their own works, and went a whoring with their own inventions•Strongs 4611:mah-al-awl´; from 5953; an act (good or bad):—doing, endeavour, invention, work..”
—Psalms 106:37-39

A three-judge panel of the U.S. Circuit Court of Appeals for the District of Columbia granted a request from the Justice Department to stay an injunction issued Aug. 23 blocking the funding. In a major victory for supporters of the research, the court said the Obama administration could resume funding the research pending a full appeal of the case.

U.S. District Judge Royce C. Lamberth, ruling in a lawsuit filed by two researchers working on alternatives to the cells, said the funding violated a federal rule that prohibits federal tax money from being used for research that involves the destruction of human embryos.

Here’s an excerpt from Thursday’s order:

O R D E R
Upon consideration of the emergency motion for stay pending appeal and for
immediate administrative stay, it is
ORDERED that the district court’s August 23, 2010 order be stayed pending
further order of the court. The purpose of this administrative stay is to give the court
sufficient opportunity to consider the merits of the emergency motion for stay and
should not be construed in any way as a ruling on the merits of that motion. See D.C.
Circuit Handbook of Practice and Internal Procedures 33 (2010). It is
FURTHER ORDERED that appellees file a response to the emergency motion
by September 14, 2010, at 4:00 p.m. The appellants may file a reply by 4:00 p.m. on
September 20, 2010. The parties are directed to hand-deliver the paper copies of their
submissions to the court by the time and date due.

The original decision was hailed by opponents of the research, who argue it is immoral to destroy human embryos. But it was condemned by supporters and advocates for patients, who said it was a major setback for one of the most promising areas of biomedical research.

In response to the order, the National Institutes of Health announced it was suspending consideration of any new grants for such research. Any researchers who had already received funding could continue their work, but their grants would not be renewed when they come up for routine review, the NIH said. As a result, hundreds of scientists around the country are scrambling to try to figure out how they are going to continue their research.

The Justice Department asked that the injunction be lifted as it appeals the decision, arguing the halt to the funding was causing irreparable harm to researchers, the federal government and patients hoping for cures.

Thursday’s decision was hailed by supporters of the research.

“We are very pleased that the Court of Appeals has stayed the preliminary injunction. It is crucial that federal funding for human embryonic stem cell research be restored permanently and this stay is a step in that direction,” said Lisa Hughes, president of the Coalition for the Advancement of Medical Research, a coalition of patient advocacy groups, scientists and research organizations that has lobbied for the funding. “While this issue continues to be argued in the courts, we call on Congress to move swiftly to resolve this issue and secure the future of this important biomedical research.”